Search results

Sort By:

Limit search:

Market access issues for transgenic plants in Canada and abroad

100%

Anderson B.

Biotechnologia

2000

issue 2

34-40

In this paper the factors affecting the commercialization of ag-biotech products in Canada destined for international markets. Public acceptance issues, lack of internationally harmonized regulatory systems and data requirements, politicized regulatory systems, intellectual property rights, unclear and inconsistent labeling laws, and the current uncertainty cultivated by the United Nations Convention on Biological Diversity (CBD) Biosafety Protocol, all contribute to market access barriers for Genetically Modified Organisms (GMOs) are discussed.